China Urinalysis Market (2024-2029)
The China Urinalysis Market was valued at $338.8 Million in 2024 and projected to reach to $663.3 Million by 2029, representing a compound annual growth rate of 14.4%. China's urinalysis market is poised for sustained growth through 2029, with the market nearly doubling from $338.8 million to $663.3 million.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China Urinalysis Market Trends and Insights
- This represents a compound annual growth rate of 14.4%, significantly outpacing global market growth.
- China's rapid urbanization, aging population, and increasing healthcare expenditure are driving demand for diagnostic testing across hospitals, clinics, and point-of-care settings. The Chinese urinalysis market benefits from government initiatives promoting preventive healthcare and early disease detection.
- China's expanding middle class and rising awareness of chronic disease screening are accelerating adoption of urinalysis testing.
- Technological advancements in automated urinalysis systems and integration with digital health platforms are reshaping China's diagnostic landscape between 2024 and 2029. China's position as a manufacturing hub for diagnostic equipment further strengthens its market position.
- The country's regulatory environment continues to evolve, with increased focus on quality standards and clinical validation, supporting sustainable market growth through the forecast period..
Key Market Statistics
- CAGR (2024-2029) 14.4% CAGR
- Market Size, 2024 ~USD 338.8 Million
- Forecast, 2029 ~USD 663.3 Million
- Country China
China Urinalysis Market Overview
Rapid Market Expansion :
China's urinalysis market is growing at 14.4% CAGR, nearly 1.5x faster than the global average of 9.6%, driven by increased healthcare investments and diagnostic adoption across urban centers.
Aging Population Dynamics :
China's demographic shift toward an aging society is significantly increasing demand for routine diagnostic testing, with urinalysis becoming a standard screening tool in geriatric care protocols.
Healthcare Infrastructure Investment :
Rapid urbanization and government healthcare reforms are expanding access to diagnostic facilities in tier-2 and tier-3 cities, creating new market opportunities beyond major metropolitan areas.
Rising Healthcare Expenditure :
Increasing disposable incomes and government healthcare spending are enabling broader adoption of preventive diagnostic testing, positioning urinalysis as a cost-effective screening solution.
China Urinalysis Market Dynamics
- This exceptional 14.4% CAGR reflects structural tailwinds including an aging population requiring frequent health monitoring, accelerating urbanization driving healthcare facility expansion, and rising healthcare awareness among middle-class consumers.
- Government initiatives promoting preventive medicine and diagnostic standardization further support market penetration. The competitive landscape is intensifying as both domestic manufacturers and international players establish production capabilities in China.
- Technological advancements in automated urinalysis systems and point-of-care testing devices are enhancing efficiency in hospitals and clinics.
- Integration with digital health platforms and electronic medical records systems is creating additional growth vectors, particularly in tier-2 and tier-3 cities where healthcare infrastructure modernization is accelerating..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- China's urinalysis market will nearly double from $338.8M (2024) to $663.3M (2029), driven by 14.4% CAGR growth.
- China's aging population and rising chronic disease prevalence are key demand drivers for urinalysis testing.
- Automation and digital health integration are transforming China's urinalysis diagnostic capabilities.
- China's regulatory improvements and manufacturing capabilities position it as a regional diagnostic leader.
Urinalysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOSPITALS & CLINICS (End User) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.6% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.3 (2024) |
| Revenue Forecast (Billions) | ~USD 6.8 (2029) |
| Segments Covered | Product, Type, Test Type, Application, End User |
China Urinalysis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Automated Urine Analyzers
- Biochemical Urine Analyzers
- Brazil
- Diabetes
- Dipsticks
- Disposables
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Kidney Diseases
- Laboratory Tests
- Liver Diseases
- Mexico
- Microscopy Analyzers
- Other Disease Screening Applications
- Poc Tests
- Point-Of-Care Urine Analyzers
- Pregnancy & Fertility Kits
- Reagents
- Rest Of Latam
- Sediment Urine Analyzers
- Semi-Automated Urine Analyzers
- Urinary Tract Infections
By Test Type
- Biochemical Tests
- Pregnancy & Fertility Tests
- Sediment Urinalysis
By Application
- Disease Screening
- Pregnancy & Fertility Testing
By End User
- Diagnostic Laboratories
- Home Care Settings
- Hospitals & Clinics
- Research Laboratories & Institutes
CHINA: URINALYSIS MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DIAGNOSTIC LABORATORIES | 136.5 | 148.1 | 162.3 | 179 | 198.8 | 222.9 | 252.3 | 288.5 | 12.2 |
| HOME CARE SETTINGS | 96.2 | 105 | 115.7 | 128.4 | 143.6 | 162.3 | 185.3 | 213.9 | 13.1 |
| HOSPITALS & CLINICS | 117.8 | 132.8 | 151.1 | 173.3 | 200.2 | 233.8 | 275.8 | 329 | 16.8 |
| RESEARCH LABORATORIES & INSTITUTES | 25.7 | 27.7 | 30.2 | 33.1 | 36.5 | 40.8 | 46 | 52.5 | 11.7 |
| TOTAL | 376.3 | 413.6 | 459.3 | 513.8 | 579 | 659.8 | 759.5 | 883.8 | 14 |
Target Audience
- In Vitro Diagnostics Manufacturers : IVD companies need China-specific market data to assess market entry feasibility, competitive positioning, and revenue potential for urinalysis products and automated analyzer systems.
- Healthcare Facility Operators : Hospital networks and diagnostic centers require market insights to justify capital investments in urinalysis equipment, understand demand trends, and optimize service offerings across regions.
- Private Equity & Investment Firms : Investors evaluating healthcare diagnostics opportunities in China need validated market sizing, growth projections, and competitive dynamics to support acquisition and portfolio company strategies.
- Medical Device Distributors : Regional and national distributors need China market intelligence to identify growth segments, forecast demand, and develop targeted sales strategies for urinalysis testing solutions.
- Healthcare Policy & Government Bodies : Government agencies and health ministries require market data to inform healthcare infrastructure planning, diagnostic standardization initiatives, and resource allocation decisions.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation ($338.8M in 2024) and verified 14.4% CAGR projections specific to China, enabling accurate financial forecasting and investment decision-making for regional expansion strategies.
- Competitive Intelligence : Understand China's competitive landscape, including domestic vs. international player positioning, market share distribution, and emerging competitors in the urinalysis segment to inform go-to-market strategies.
- Demographic & Regulatory Insights : Access detailed analysis of China's aging population trends, urbanization patterns, and healthcare policy drivers that are accelerating urinalysis adoption across hospitals, clinics, and point-of-care settings.
- Regional Opportunity Mapping : Identify high-growth sub-regions and tier-2/tier-3 city opportunities where healthcare infrastructure modernization is creating untapped demand for diagnostic testing solutions.
- Strategic Partnership Data : Leverage market intelligence to identify potential distribution partners, technology collaborators, and acquisition targets within China's rapidly consolidating urinalysis diagnostics ecosystem.
Frequently asked questions
What is the current size of China's urinalysis market?
China's urinalysis market was valued at $338.8 million in 2024 and is projected to reach $663.3 million by 2029.
What is the growth rate of China's urinalysis market?
China's urinalysis market is growing at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
What factors are driving growth in China's urinalysis market?
Key drivers include China's aging population, rising chronic disease prevalence, government healthcare initiatives, urbanization, and technological advancements in diagnostic automation.
How does China's urinalysis market compare to global growth?
China's 14.4% CAGR significantly exceeds the global urinalysis market CAGR of 9.6%, reflecting stronger regional demand and healthcare investment.
What technological trends are shaping China's urinalysis market?
Automated urinalysis systems, digital health platform integration, and point-of-care testing innovations are transforming China's diagnostic landscape.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Get the Full Urinalysis Market Report
Full forecast, segment splits, and company analysis for all Urinalysis Market.
- Canada Urinalysis Market
- US Urinalysis Market
- Germany Urinalysis Market
- UK Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- Japan Urinalysis Market
- India Urinalysis Market
- Australia Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
- Mexico Urinalysis Market
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
